Health Cor Management, L.P. Affimed N.V. Transaction History

Health Cor Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$5.37 - $7.07 $4.48 Million - $5.9 Million	-833,983 Reduced 32.63%	1,721,925 $9.51 Million
Q3 2021 Nov 15, 2021	BUY	$5.54 - $7.51 $736,509 - $998,409	132,944 Added 5.49%	2,555,908 $15.8 Million
Q2 2021 Aug 16, 2021	BUY	$7.78 - $11.4 $6.5 Million - $9.52 Million	835,020 Added 52.58%	2,422,964 $20.6 Million
Q1 2021 May 17, 2021	BUY	$5.12 - $8.48 $8.13 Million - $13.5 Million	1,587,944 New	1,587,944 $12.6 Million

1.09M

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $520M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.